Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10136-2 | TPCA-1 | LSM-1136 | 9903786 | ||
10274-1 | SB-3CT | LSM-4293 | 9883002 | ||
10273-1 | Purvalanol A | LSM-3118 | 456214 | ||
10262-1 | L-779450 | LSM-4283 | 9950176 | ||
10271-2 | PD 98059 | LSM-3394 | 4713 | ||
10270-1 | Oxamflatin | LSM-4290 | 4611 | ||
10268-1 | Nutlin 3a | LSM-6351 | 11433190 | ||
10228-2 | IKK16 | LSM-2309 | 9549298 | ||
10267-1 | NU6102 | LSM-4287 | 4566 | ||
10237-1 | 5-DFUR | 5-FdUR; Doxifluridine | LSM-6359 | 18343 | |
10248-1 | Doxorubicin | Adriamycin | LSM-4062 | 31703 | |
10283-1 | XRP44X | AG-G-87906 | LSM-4298 | 10339779 | |
10272-1 | Pemetrexed | Alimta | LSM-6353 | 446556 | |
10099-2 | Nilotinib | AMN-107 | LSM-1099 | 644241 | |
10261-1 | Ixabepilone | Azaepothilone B; Ixempra | LSM-43293 | 216344 | |
10056-2 | Selumetinib | AZD6244; Array142886 | LSM-1056 | 10127622 | |
10508-1 | FTase Inhibitor I | B581 | 132887 | ||
10008-3 | Sorafenib | BAY-439006 | LSM-1008 | 216239 | |
10232-2 | Dactolisib | BEZ235; NVP-BEZ235 | LSM-4255 | 11977753 | |
10133-2 | Afatinib | BIBW-2992 | LSM-43226 | 57519523 | |
10258-1 | Ibandronate | Boniva | LSM-4279 | 44828485 | |
10245-1 | Cisplatin | CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat | LSM-4268 | ||
10230-2 | Lestaurtinib | CEP-701 | LSM-1231 | 126565 | |
10048 | PD184352 | CI-1040 | LSM-1048 | 6918454 | |
10048-6 | PD184352 | CI-1040 | LSM-1048 | 6918454 |